Generate a tailored SOP for Dr. Petros Tsantoulis. Improve your application with a focused, well-structured draft.
Petros Tsantoulis is the lab leader at the Translational Research Centre on Oncohaematology at the University of Geneva. His research focuses on precision oncology, emphasizing the development of biomarkers to inform cancer prognosis and predict treatment response. He is dedicated to integrating genetic alterations into clinical practices, enhancing decision-making in personalized oncology. Dr. Tsantoulis has significant experience in collaborating with the Bioinformatics Core Facility at the Swiss Institute of Bioinformatics, utilizing advanced software and bioinformatic techniques for biomarker exploration. His work has led to the establishment of the Molecular Tumor Board, which unites experts from oncology, pathology, genetics, and bioinformatics to provide advanced molecular analyses within a clinical environment. Dr. Tsantoulis is also involved in national networks aimed at improving the use of clinical data for robust biomarker development. His educational background includes a medical degree from the University of Athens and a doctorate focusing on double-strand breaks in cancer models. He has received post-graduate specialization as an Oncologist and actively teaches at various academic levels, inspiring future physicians with his passion for science and medicine.
Translational Research Centre Oncohaematology • Geneva, Switzerland
Leading research on precision oncology with a focus on biomarker development and clinical application.
Hôpital Universitaire de Genève • Geneva, Switzerland
Specialized in Oncology and gained experience in various medical departments.
Includes Department of Management, Finance, Economics, and Statistics programs. GMAT is strongly encouraged but not mandatory for most GSEM masters.